Chen Danyang, Tang Yingxin, Nie Hao, Zhang Ping, Wang Wenzhi, Dong Qiang, Wu Guofeng, Xue Mengzhou, Tang Yuping, Liu Wenjie, Pan Chao, Tang Zhouping
Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Neurol. 2021 Sep 10;12:727962. doi: 10.3389/fneur.2021.727962. eCollection 2021.
Primary brainstem hemorrhage (PBSH) is the most fatal subtype of intracerebral hemorrhage and is invariably associated with poor prognosis. Several prognostic factors are involved, of which the two most predominant and consistent are the initial level of consciousness and hemorrhage size. Other predictors, such as age, hyperthermia, and hydrocephalus, are generally not dependable indicators for making prognoses. Scoring systems have now been developed that can predict mortality and functional outcomes in patients suffering from PBSH, which can thus guide treatment decision-making. A novel grading scale, entitled "the new primary pontine hemorrhage (PPH) score," represents the latest approach in scoring systems. In this system, patients with a score of 2-3 points appear to benefit from surgical management, although this claim requires further verification. The four main surgical options for the treatment of PBSH are craniotomy, stereotactic hematoma puncture and drainage, endoscopic hematoma removal, and external ventricular drainage. Nevertheless, the management of PBSH still primarily involves conservative treatment methods and surgery is generally not recommended, according to current practice. However, the ongoing clinical trial, entitled Safety and Efficacy of Surgical Treatment in Severe Primary Pontine Hemorrhage Evacuation (STIPE), should provide additional evidence to support the surgical treatment of PBSH. Therefore, we advocate the update of epidemiological data and re-evaluation of PBSH treatment in a contemporary context.
原发性脑干出血(PBSH)是脑出血最致命的亚型,预后总是很差。涉及多种预后因素,其中最主要且一致的两个因素是初始意识水平和出血大小。其他预测因素,如年龄、体温过高和脑积水,通常不是可靠的预后指标。现在已经开发出了能够预测PBSH患者死亡率和功能结局的评分系统,从而可以指导治疗决策。一种名为“新原发性脑桥出血(PPH)评分”的新型分级量表是评分系统中的最新方法。在该系统中,评分为2 - 3分的患者似乎能从手术治疗中获益,不过这一说法还需要进一步验证。治疗PBSH的四种主要手术选择是开颅手术、立体定向血肿穿刺引流、内镜下血肿清除和脑室外引流。然而,根据目前的实践,PBSH的治疗仍主要采用保守治疗方法,一般不建议手术。不过,正在进行的名为“严重原发性脑桥出血清除手术治疗的安全性和有效性(STIPE)”的临床试验应该会提供更多证据来支持PBSH的手术治疗。因此,我们主张在当代背景下更新流行病学数据并重新评估PBSH的治疗。